Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

1 hr ago | CNN

Experimental Ebola vaccine begins

A highly anticipated test of an experimental Ebola vaccine will begin this week at the National Institutes of Health, amid mounting anxiety about the spread of the deadly virus in West Africa.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Infectious Diseases, GlaxoSmithKline

8 hrs ago | West Australian

Cipla launches copy of GSK's top asthma drug in Germany, Sweden

Cipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipla in Sweden, the Mumbai-based company said in a statement on Monday.

Comment?

Related Topix: Medicine, Health, Asthma, Biotech

12 hrs ago | West Australian

Go-ahead for WA opium crops

The State Government will support farmers who want to grow opium, one of the most dangerous but extremely lucrative crops, after the Abbott Government decided to allow poppies to be grown outside Tasmania.

Comment?

Related Topix: Drugs, Agriculture, Science, Australia, Oceania, World News, Biotech

16 hrs ago | Seeking Alpha

New Criminal Actions Against Volkswagen, U.S. Meat Supplier

Most of the recent flood of probes against foreign firms have been of the civil variety, resulting in stiff fines for anti-competitive behavior but few or no criminal charges and prison time.

Comment?

Related Topix: Restaurant Management, Mcdonalds, Biotech

19 hrs ago | Indian Television

GlaxoSmithKline healthcare Q2-2014 marketing spend down 24 per cent q-o-q

BENGALURU: Nutritional products and OTC drug major GlaxoSmithKline Consumer Healthcare Limited spent 23.9 per cent less towards advertising and sales promotion in the quarter ended 30 June 2014 at Rs 141.40 crore versus Rs 185.75 crore in Q1-2014 and just 2.8 per cent more than the Rs 137.56 crore in Q2-2013.

Comment?

Related Topix: GlaxoSmithKline, Marketing, Biotech, Medicine, Healthcare Industry

Sun Aug 31, 2014

KSL-TV

US to begin safety testing Ebola vaccine next week

The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Bethesda, MD

Reuters

Press Digest-Sunday British Business - Aug 31

British newspapers reported the following business stories on Sunday. Reuters has not independently verified these media reports and does not vouch for their accuracy.

Comment?

Related Topix: Biotech, Home Listing, Home

Sat Aug 30, 2014

San Bernardino County Sun

Liberian Ebola survivor praises experimental drug

A woman, center, reacts as she and others celebrate on the streets outside of West Point, that have been closed in by Liberian security forces to stop all movement the past week in a attempt to control the Ebola outbreak in Monrovia, Liberia, Saturday, Aug. 30, 2014.

Comment?

Related Topix: Liberia, World News, Africa, Biotech, Infectious Diseases, Medicine, GlaxoSmithKline, Healthcare Industry

Fri Aug 29, 2014

Biopharm

NIH Launches Human Safety Study of Ebola Vaccine Candidate

Initial human testing on a vaccine to prevent Ebola virus co-developed by the National Institute of Allergy and Infectious Diseases , part of the National Institute of Health, and GlaxoSmithKline will begin the week of Sept.

Comment?

Related Topix: Infectious Diseases, Medicine, Biotech, Genetics

Seeking Alpha

Is GlaxoSmithKline A Solid Long-Term Investment?

The Chinese issues have caused the stock price to fall and we believe this fall has created a buying opportunity.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Business Journal

Durham's Patheon puts itself closer to customers in North America

When Jim Mullen , CEO of Patheon Pharma's parent holding company, started thinking about an acquisition in the United States, it wasn't a question of "if," but "whom?" Patheon, a contract manufacturer of pharmaceutical products, had production facilities in Australia and the Netherlands, but nothing closer to North America where many of its ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck

AmericanBankingNews.com

GlaxoSmithKline plc Receives Consensus Rating of "Hold" from Analysts

GlaxoSmithKline plc has been given an average rating of "Hold" by the twenty brokerages that are currently covering the stock, AmericanBankingNews.com reports .

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

Thu Aug 28, 2014

Yahoo!

Obama accuses Russia, says no US military action in Ukraine

President Obama said at a press conference on Thursday that Russia has deliberately and repeatedly violated the sovereignty and territorial integrity of Ukraine.

Comment?

Related Topix: Hillary Clinton, US Politics, US News, Missouri, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Seeking Alpha

AbbVie: Growth Story Or Patent Expiration Nightmare?

AbbVie is a global biopharmaceutical company, with over 25,000 employees and products sold in over 170 countries.

Comment?

Related Topix: Abbott Laboratories, AstraZeneca, Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Pfizer, GlaxoSmithKline

The Standard

Ebola vaccine trials being fast-tracked: researchers

Safety trials on an Ebola vaccine are being fast-tracked, meaning it could be given to healthy volunteers as early as September, researchers said Thursday.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry, Charitable Organizations, Wellcome Trust

Yahoo!

Regional crisis talks as Ebola death toll tops 1,500

Ebola-hit nations met for crisis talks on Thursday as the death toll topped 1,500 and the World Health Organization warned that the number of cases could exceed 20,000 before the outbreak is stemmed.

Comment?

Related Topix: Nigeria, World News, Africa, Biotech, Epidemic, Natural Disasters, Liberia, Sierra Leone

WAPT-TV Jackson

Experimental Ebola vaccine trial starts soon

A highly anticipated test of an experimental Ebola vaccine will begin next week at the National Institutes of Health, amid mounting anxiety about the spread of the deadly outbreak in West Africa.

Comment?

Related Topix: Biotech, Medicine, Food and Drug Administration, Infectious Diseases, Genetics

Asbury Park Press

US to begin safety testing Ebola vaccine next weekUS to begin safety...

US to begin safety testing Ebola vaccine next week Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus.

Comment?

Related Topix: Sierra Leone, World News, Africa, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Bethesda, MD

TheStreet.com

Why GlaxoSmithKline (GSK) Stock Is Gaining Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Mozilla, Infectious Diseases

ITV

Up to 10,000 Ebola vaccines to be made during trials

Up to 10,000 doses of an experimental Ebola vaccine will be produced at the same time that clinical trials of the drug are taking place so they can be ready for emergency deployment if it proves effective.

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••